Core Scientific Ratios (2020-2026) | CORZ

Ratios Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter)
32.59%51.64%46.84%36.36%7.76%-16.65%-38.96%26.34%29.12%13.66%27.69%43.31%27.51%-0.16%5.02%10.33%6.39%4.81%26.02%26.12%
EBT Margin (Quarter)
-4.38%-15.42%25.50%-220.13%-523.95%-260.90%-376.36%-0.24%-7.19%-36.34%-137.64%117.63%-639.26%-477.30%-306.32%724.87%-1,191.23%-177.43%270.87%-300.74%
EBIT Margin (Quarter)
20.62%4.23%33.85%-13.88%-637.54%-246.89%-524.60%6.30%7.46%-10.67%2.77%30.80%-64.27%-43.23%-68.89%-59.15%-33.43%-67.56%-147.28%-269.36%
EBITDA Margin (Quarter)
20.62%4.23%33.85%-13.88%-637.54%-246.89%-524.60%6.30%7.46%-10.67%2.77%30.80%-64.27%-43.23%-68.89%-59.15%-33.43%-67.56%-147.28%-269.36%
Operating Margin (Quarter)
20.62%4.23%33.85%-13.88%-637.54%-246.89%-524.60%6.30%7.46%-10.67%2.77%30.80%-64.27%-43.23%-68.89%-59.15%-33.43%-67.56%-147.28%-269.36%
Net Margin (Quarter)
-4.53%-13.24%17.11%-242.16%-494.25%-267.45%-358.64%-0.32%-7.27%-36.44%-137.88%117.51%-639.33%-477.41%-306.71%724.62%-1,191.49%-177.55%270.77%-301.26%
FCF Margin (Quarter)
-219.20%-107.96%74.82%-13.57%-43.38%-35.25%147.07%15.25%14.03%2.38%7.09%12.33%0.82%-63.31%-15.75%-162.24%-111.00%-138.97%-152.62%-120.92%
Efficiency
Assets Average (Quarter)
347.67M347.34M1,392.97M2,571.46M2,274.60M1,624.58M1,105.84M783.85M755.44M728.16M708.81M763.06M739.08M744.39M1,150.27M1,487.00M1,674.40M2,011.02M2,259.47M2,708.60M
Equity Average (Quarter)
96.52M22.42M645.09M1,233.96M771.58M244.74M-168.16M-403.40M-394.95M-405.58M-507.83M-457.73M-749.82M-1003.90M-884.85M-625.93M-750.40M-1222.31M-1107.69M-1134.21M
Invested Capital (Quarter)
104.59M-35.49M1,341.21M1,154.71M422.26M146.07M-409.35M-397.46M-392.44M-362.98M-541.42M-314.32M-1177.87M-824.27M-941.38M-307.65M-1191.99M-1252.64M-962.74M-220.69M
Asset Utilization Ratio (Quarter)
0.390.270.340.510.580.730.700.660.710.740.780.750.440.280.210.170.140.13
Leverage & Solvency
Debt to Equity (Quarter)
0.09-0.300.490.962.060.070.00-1.62-1.15-1.75-0.45-0.57-1.14-3.47-0.89-0.85-1.10-1.57
Debt Ratio (Quarter)
0.030.040.270.400.470.000.000.960.960.680.790.580.730.720.570.490.450.67
Equity Ratio (Quarter)
0.28-0.150.550.420.230.05-0.51-0.52-0.52-0.59-0.84-0.39-1.78-1.00-0.64-0.21-0.64-0.58-0.41-0.43
Valuation
Enterprise Value (Quarter)
-2.04M-1.60M-131.68M-375.51M-140.44M-37.60M-52.24M-69.29M-76.76M-63.94M-69.71M-114.28M-97.11M-253.78M-836.98M-698.68M-581.30M-453.40M-311.38M-1065.39M
Return Ratios
Return on Sales (Quarter)
0.00%0.00%0.00%-0.02%-0.05%-0.03%-0.04%0.00%0.00%0.00%-0.01%0.01%-0.06%-0.05%-0.03%0.07%-0.12%-0.02%0.03%-0.03%
Return on Capital Employed (Quarter)
8.54%12.26%4.44%-54.90%-408.65%-229.54%-357.55%-179.62%-151.88%4.07%9.05%-6.56%-10.89%-13.99%-18.92%-16.19%-14.43%-16.62%-1,087.06%
Return on Invested Capital (Quarter)
0.00%0.00%-0.01%-0.05%0.16%0.05%0.03%0.02%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%
Return on Assets (Quarter)
0.00%0.00%0.00%-0.01%-0.01%-0.02%-0.02%-0.01%-0.01%0.00%0.00%-0.01%-0.02%-0.01%-0.01%-0.01%0.00%0.00%0.00%
Return on Equity (Quarter)
-0.01%0.00%0.00%-0.02%-0.07%0.13%0.04%0.02%0.01%0.00%0.00%0.01%0.01%0.02%0.02%0.01%0.01%0.00%0.01%